Patients with rheumatoid arthritis (RA) may have an ally to treat the pain of recurrent inflammation that occurs in the joints of the body.
That’s because, according to research by the Faculty of Medicine at the University of Virginia ( UVA ), a gene called ELMO1 may be closely related to RA symptoms.
The disease, which affects 1% of the world population, is characterized by pain and can cause limitation of some movements and impairment of bone structure.
And all this happens because the carrier’s organism causes the body’s joints to be affected by the defense cells themselves, and may have reflexes in other organs and systems.
To avoid this, the discovery suggests that inhibition of this causative gene (ELMO1) may cause the symptoms of rheumatoid arthritis to subside.
So, the next step is to find a drug that fulfills this function.
Future drugs for rheumatoid arthritis
Research is important for the treatment of the disease, since it can be used to develop drugs that, in its action, control ELMO1.
This would be necessary because despite being a defense cell, it is related to the symptoms of arthritis.
